Serge Leyvraz

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 3

Top Topics

Chronic Lymphocytic Leukemia

Signaling Pathway

Top Venues

JCO precision oncology

Cancer research communications

This page only lists publications with an associated author ORCID identifier.

Publications

Stefan Habringer, Jana Ihlow, Karsten Kleo, Anna Klostermann, Max Schmidt, Lidan Chai, Maren Knödler, Serge Leyvraz, Christian Sigler, Bruno Valentin Sinn, Georg Maschmeyer, Yvette Jegodka, Manuela Benary, Claus-Eric Ott, Ingeborg Tinhofer, Reinhold Schäfer, Markus Möbs, Ulrich Bernd Keller, Ulrich Keilholz, Damian T Rieke
A diagnostic challenge of KIT p.V559D and BRAF p.G469A mutations in a paragastric mass. The oncologist (2024)
Glenn J Hanna, Anastasios Stathis, Elena Lopez-Miranda, Fabricio Racca, Doris V Quon, Serge Leyvraz, Dagmar Hess, Bhumsuk Keam, Jordi Rodon Ahnert, Myung-Ju Ahn, Hye Ryun Kim, Andreas Schneeweiß, Josep-María Ribera, Daniel J DeAngelo, Jose Manuel Perez Garcia, Javier Cortes, Oliver Schönborn-Kellenberger, Dirk Weber, Pavel Pisa, Michael Bauer, Laura Beni, Maria Bobadilla, Raj Lehal, Michele Vigolo, Florian D Vogl, Elena Garralda
A Phase I Study of the Pan-Notch Inhibitor CB-103 for Patients with Advanced Adenoid Cystic Carcinoma and Other Tumors. Cancer research communications 3 (9) (2023)
Alexander E Drilon, Daniel Shao-Weng Tan, Ulrik N Lassen, Serge Leyvraz, Yongmei Liu, Jyoti D Patel, Lee S Rosen, Benjamin Solomon, Ricarda Norenberg, Laura Dima, Nicoletta Brega, Lin Shen, Victor Moreno, Shivaani Kummar, Jessica J Lin
Efficacy and Safety of Larotrectinib in Patients With Tropomyosin Receptor Kinase Fusion-Positive Lung Cancers. JCO precision oncology 6 (2022)